Business
Single-shot Johnson & Johnson vaccine 66 per cent effective against COVID-19, study shows – The Age
The company says its vaccine is 72 per cent effective in preventing COVID-19 in the US but a lower rate of 66 per cent was observed globally in the large trial…
J&J plans to seek emergency use authorisation in the US within a week. It expects to supply 100 million doses to the US by June and a billion doses globally by years end but declined to say how much could be ready if the Food and Drug Administration gives the green light.
Defeating the scourge that has killed more than 2 million people worldwide will require vaccinating billions. The shots being rolled out in different countries so far all require two doses a few weeks apart for full protection….
-
Noosa News23 hours agoTwo trapped and fighting for life after major three-vehicle crash in Brisbane
-
Business24 hours agoUp 105% in a year, are Pro Medicus shares still a good buy today?
-
Noosa News19 hours agoQueensland man sentenced to four years imprisonment after string of terror offences
-
Business22 hours agoEverything you need to know about the Coles dividend